{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T12:17:06Z","timestamp":1789301826863,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Key Research and Devepolment Program of China","award":["2017YFC0909003"],"award-info":[{"award-number":["2017YFC0909003"]}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["17411964400"],"award-info":[{"award-number":["17411964400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YG2016MS46"],"award-info":[{"award-number":["YG2016MS46"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s10067-020-04949-0","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T11:03:01Z","timestamp":1583319781000},"page":"2379-2386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Macrophage activation syndrome associated with adult-onset Still\u2019s disease: a multicenter retrospective analysis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-8433","authenticated-orcid":false,"given":"Ran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"de Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"4949_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2147\/OARRR.S83948","volume":"8","author":"M Siddiqui","year":"2016","unstructured":"Siddiqui M, Putman MS, Dua AB (2016) Adult-onset Still\u2019s disease: current challenges and future prospects. Open Access Rheumatol 8:17\u201322. https:\/\/doi.org\/10.2147\/OARRR.S83948","journal-title":"Open Access Rheumatol"},{"key":"4949_CR2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.12659\/ajcr.901846","volume":"18","author":"M Agha-Abbaslou","year":"2017","unstructured":"Agha-Abbaslou M, Bensaci AM, Dike O et al (2017) Adult-onset Still\u2019s disease: still a serious health problem (a case report and literature review). Am J Case Rep 18:119\u2013124. https:\/\/doi.org\/10.12659\/ajcr.901846","journal-title":"Am J Case Rep"},{"issue":"5","key":"4949_CR3","first-page":"665","volume":"142","author":"EB Larson","year":"1985","unstructured":"Larson EB (1985) Adult Still\u2019s disease--recognition of a clinical syndrome and recent experience. West J Med 142(5):665\u2013671","journal-title":"West J Med"},{"issue":"11","key":"4949_CR4","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.15537\/smj.2016.11.15367","volume":"37","author":"AZ Qureshi","year":"2016","unstructured":"Qureshi AZ, AlSheef M, Qureshi WT et al (2016) Adult onset Still\u2019s disease with dermatopathic lymphadenopathy. Saudi Med J 37(11):1265\u20131267. https:\/\/doi.org\/10.15537\/smj.2016.11.15367","journal-title":"Saudi Med J"},{"issue":"30","key":"4949_CR5","doi-asserted-by":"publisher","first-page":"e4258","DOI":"10.1097\/MD.0000000000004258","volume":"95","author":"M Gerfaud-Valentin","year":"2016","unstructured":"Gerfaud-Valentin M, Cottin V, Jamilloux Y, Hot A, Gaillard-Coadon A, Durieu I, Broussolle C, Iwaz J, S\u00e8ve P (2016) Parenchymal lung involvement in adult-onset Still disease: a STROBE-compliant case series and literature review. Medicine 95(30):e4258. https:\/\/doi.org\/10.1097\/MD.0000000000004258","journal-title":"Medicine"},{"issue":"3","key":"4949_CR6","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3892\/etm.2016.3512","volume":"12","author":"XT Xi","year":"2016","unstructured":"Xi XT, Wang MJ, Huang RY, Ding BH (2016) Adult onset Still\u2019s disease accompanied by acute respiratory distress syndrome: a case report. Exp Ther Med 12(3):1817\u20131821. https:\/\/doi.org\/10.3892\/etm.2016.3512","journal-title":"Exp Ther Med"},{"key":"4949_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.rmcr.2017.07.001","volume":"22","author":"A Guerrieri","year":"2017","unstructured":"Guerrieri A, Angeletti G, Mazzolini M, Bassi I, Nava S (2017) Pulmonary involvement in adult Still\u2019s disease: case report and brief review of literature. Respir Med Case Rep 22:91\u201394. https:\/\/doi.org\/10.1016\/j.rmcr.2017.07.001","journal-title":"Respir Med Case Rep"},{"issue":"1","key":"4949_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12291-016-0559-8","volume":"32","author":"N Verma","year":"2017","unstructured":"Verma N, Chakraverty J, Baweja P, Girotra A, Chatterjee L, Chugh M (2017) Extremely high ferritinemia associated with haemophagocytic lympho histiocytosis (HLH). Indian J Clin Biochem 32(1):117\u2013120. https:\/\/doi.org\/10.1007\/s12291-016-0559-8","journal-title":"Indian J Clin Biochem"},{"key":"4949_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","volume":"66","author":"GS Schulert","year":"2015","unstructured":"Schulert GS, Grom AA (2015) Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu Rev Med 66:145\u2013159. https:\/\/doi.org\/10.1146\/annurev-med-061813-012806","journal-title":"Annu Rev Med"},{"key":"4949_CR10","doi-asserted-by":"publisher","first-page":"2071815","DOI":"10.1155\/2016\/2071815","volume":"2016","author":"A Agnihotri","year":"2016","unstructured":"Agnihotri A, Ruff A, Gotterer L, Walker A, McKenney A, Brateanu A (2016) Adult onset Still\u2019s disease associated with mycoplasma pneumoniae infection and hemophagocytic lymphohistiocytosis. Case Rep Med 2016:2071815. https:\/\/doi.org\/10.1155\/2016\/2071815","journal-title":"Case Rep Med"},{"issue":"2","key":"4949_CR11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124\u2013131","journal-title":"Pediatr Blood Cancer"},{"key":"4949_CR12","doi-asserted-by":"publisher","unstructured":"Filipovich AH (2009) Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematology Am Soc Hematol Educ Program:127\u2013131. https:\/\/doi.org\/10.1182\/asheducation-2009.1.127 [published Online First: 2009\/12\/17]","DOI":"10.1182\/asheducation-2009.1.127"},{"issue":"9","key":"4949_CR13","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O et al (2014) Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66(9):2613\u20132620. https:\/\/doi.org\/10.1002\/art.38690 [published Online First: 2014\/05\/02]","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"4949_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S et al (2016) 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol 68(3):566\u2013576. https:\/\/doi.org\/10.1002\/art.39332","journal-title":"Arthritis Rheumatol"},{"key":"4949_CR15","doi-asserted-by":"publisher","unstructured":"Minoia F, Bovis F, Davi S et al (2019) Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215211 [published Online First: 2019\/07\/13]","DOI":"10.1136\/annrheumdis-2019-215211"},{"issue":"7","key":"4949_CR16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3899\/jrheum.161286","volume":"44","author":"SS Ahn","year":"2017","unstructured":"Ahn SS, Yoo BW, Jung SM et al (2017) Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease. J Rheumatol 44(7):996\u20131003. https:\/\/doi.org\/10.3899\/jrheum.161286","journal-title":"J Rheumatol"},{"key":"4949_CR17","doi-asserted-by":"publisher","unstructured":"Wang R, Li T, Ye S et al (2019) Application of MS score in macrophage activation syndrome patients associated with adult onset Still\u2019s disease. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216286 [published Online First: 2019\/10\/16]","DOI":"10.1136\/annrheumdis-2019-216286"},{"issue":"2","key":"4949_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/MPH.0b013e3181923cb4","volume":"31","author":"AA Gupta","year":"2009","unstructured":"Gupta AA, Tyrrell P, Valani R et al (2009) Experience with hemophagocytic lymphohistiocytosis\/macrophage activation syndrome at a single institution. J Pediatr Hematol Oncol 31(2):81\u201384. https:\/\/doi.org\/10.1097\/MPH.0b013e3181923cb4 [published Online First: 2009\/02\/06]","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"4949_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/art.39329","volume":"68","author":"SW Canna","year":"2016","unstructured":"Canna SW, Nigrovic PA (2016) Editorial: 21st century storm chasers: defining macrophage activation syndrome. Arthritis Rheumatol 68(3):557\u2013560. https:\/\/doi.org\/10.1002\/art.39329","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"4949_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/bor.0000000000000093","volume":"26","author":"LK Weaver","year":"2014","unstructured":"Weaver LK, Behrens EM (2014) Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Curr Opin Rheumatol 26(5):562\u2013569. https:\/\/doi.org\/10.1097\/bor.0000000000000093","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"4949_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10067-017-3625-6","volume":"37","author":"AC Liu","year":"2018","unstructured":"Liu AC, Yang Y, Li MT et al (2018) Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China. Clin Rheumatol 37(1):93\u2013100. https:\/\/doi.org\/10.1007\/s10067-017-3625-6 [published Online First: 2017\/04\/15]","journal-title":"Clin Rheumatol"},{"issue":"8","key":"4949_CR22","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1002\/art.38672","volume":"66","author":"S Kumakura","year":"2014","unstructured":"Kumakura S, Murakawa Y (2014) Clinical characteristics and treatment outcomes of autoimmune-associated hemophagocytic syndrome in adults. Arthritis Rheumatol 66(8):2297\u20132307. https:\/\/doi.org\/10.1002\/art.38672","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"4949_CR23","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.38802","volume":"66","author":"F Minoia","year":"2014","unstructured":"Minoia F, Davi S, Horne A et al (2014) Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 66(11):3160\u20133169. https:\/\/doi.org\/10.1002\/art.38802","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"4949_CR24","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/cc11256","volume":"16","author":"D Demirkol","year":"2012","unstructured":"Demirkol D, Yildizdas D, Bayrakci B, Karapinar B, Kendirli T, Koroglu TF, Dursun O, Erkek N, Gedik H, Citak A, Kesici S, Karabocuoglu M, Carcillo JA, Turkish Secondary HLH\/MAS Critical Care Study Group (2012) Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: what is the treatment? Crit Care 16(2):R52. https:\/\/doi.org\/10.1186\/cc11256","journal-title":"Crit Care"},{"issue":"7","key":"4949_CR25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00043426-200210000-00011","volume":"24","author":"L Sung","year":"2002","unstructured":"Sung L, King SM, Carcao M et al (2002) Adverse outcomes in primary hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol 24(7):550\u2013554","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"4949_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jbspin.2013.04.011","volume":"80","author":"C Banse","year":"2013","unstructured":"Banse C, Vittecoq O, Benhamou Y et al (2013) Reactive macrophage activation syndrome possibly triggered by canakinumab in a patient with adult-onset Still's disease. Joint Bone Spine 80(6):653\u2013655. https:\/\/doi.org\/10.1016\/j.jbspin.2013.04.011","journal-title":"Joint Bone Spine"},{"issue":"24","key":"4949_CR27","doi-asserted-by":"publisher","first-page":"e6656","DOI":"10.1097\/MD.0000000000006656","volume":"96","author":"F Parisi","year":"2017","unstructured":"Parisi F, Paglionico A, Varriano V, Ferraccioli G, Gremese E (2017) Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: a case report treated with high doses (8 mg\/kg\/d) of anakinra. Medicine 96(24):e6656. https:\/\/doi.org\/10.1097\/MD.0000000000006656","journal-title":"Medicine"},{"issue":"12","key":"4949_CR28","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10067-018-4095-1","volume":"37","author":"HE Sonmez","year":"2018","unstructured":"Sonmez HE, Demir S, Bilginer Y et al (2018) Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol 37(12):3329\u20133335. https:\/\/doi.org\/10.1007\/s10067-018-4095-1 [published Online First: 2018\/04\/18]","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4949_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/jca.21570","volume":"33","author":"N Kinjo","year":"2018","unstructured":"Kinjo N, Hamada K, Hirayama C, Shimizu M (2018) Role of plasma exchange, leukocytapheresis, and plasma diafiltration in management of refractory macrophage activation syndrome. J Clin Apher 33(1):117\u2013120. https:\/\/doi.org\/10.1002\/jca.21570","journal-title":"J Clin Apher"},{"issue":"7","key":"4949_CR30","first-page":"324","volume":"74","author":"J Jin","year":"2016","unstructured":"Jin J (2016) A continuous infusion of etoposide and doxorubicin for refractory MAS management. Neth J Med 74(7):324\u2013325","journal-title":"Neth J Med"},{"key":"4949_CR31","doi-asserted-by":"publisher","unstructured":"Lee YH (2018) Tocilizumab in patients with adult-onset Still\u2019s disease refractory to glucocorticoid treatment. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214635","DOI":"10.1136\/annrheumdis-2018-214635"},{"issue":"1","key":"4949_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/1756-185X.12170","volume":"17","author":"RN Sarkar","year":"2014","unstructured":"Sarkar RN, Bhattacharya R, Bhattacharyya K et al (2014) Adult onset Still\u2019s disease with persistent skin lesions complicated by secondary hemophagocytic lymphohistiocytosis. Int J Rheum Dis 17(1):118\u2013121. https:\/\/doi.org\/10.1111\/1756-185X.12170 [published Online First: 2013\/10\/15]","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"4949_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.29333\/ejgm\/81893","volume":"14","author":"G Sargin","year":"2017","unstructured":"Sargin G, Senturk T, Yavasoglu I et al (2017) Extremely high serum ferritin level in a patient with hemophagocytic syndrome and adult-onset Still\u2019s disease. Eur J Gen Med 14(3):81\u201383. https:\/\/doi.org\/10.29333\/ejgm\/81893","journal-title":"Eur J Gen Med"},{"key":"4949_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1741-7015-11-185","volume":"11","author":"C Rosario","year":"2013","unstructured":"Rosario C, Zandman-Goddard G, Meyron-Holtz EG et al (2013) The hyperferritinemic syndrome: macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med 11:185. https:\/\/doi.org\/10.1186\/1741-7015-11-185","journal-title":"BMC Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04949-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-04949-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04949-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:15:23Z","timestamp":1614816923000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-04949-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4949"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-04949-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"19 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}